Home › Funds › BRAIDWELL LP › ZURA

BRAIDWELL LP position in ZURA

ZURA BIO · Health Care

BRAIDWELL LP reported holding 3,980,295 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$23.5M, representing 0.92% of its reported portfolio and ranking #44 among its reported holdings. BRAIDWELL LP has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)3.98M sh
Reported value held$23.48M
Portfolio Weight0.92%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's ZURA position evolved

BRAIDWELL LP first disclosed a stake in ZURA in Q3 2024 at 2,472,806 shares (US$10.0M). The position peaked in Q1 2026 at 3,988,989 shares, worth US$23.7M. Across 8 filings, BRAIDWELL LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 3,980,295 shares valued at US$23.5M. Notable position changes include a 29% increase in Q4 2025 (shares rose 14% over the following quarter), a 25% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.47M $10.04M New
Q4 2024 2.47M $6.18M Hold
Q1 2025 2.47M $3.19M Hold
Q2 2025 2.47M $2.60M Hold
Q3 2025 2.47M $10.71M Hold
Q4 2025 3.18M $16.67M Add
Q1 2026 3.99M $23.73M Add
Q2 2026 3.98M $23.48M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZURA and 13F data

ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZURA

All ZURA fund holders →

FAQ

How long has BRAIDWELL LP held ZURA?

BRAIDWELL LP has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is BRAIDWELL LP's current position in ZURA?

As of Q2 2026, BRAIDWELL LP holds 3.98M shares of ZURA (ZURA BIO), valued at $23.48M, representing 0.92% of its reported portfolio and ranking #44.

Has BRAIDWELL LP been buying or selling ZURA?

In the latest 13F filing (Q2 2026), BRAIDWELL LP held unchanged its position in ZURA. The position peaked in Q1 2026 at 3.99M shares.

Which other funds hold ZURA?

Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.